Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

DDefinium Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
D

Definium Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Sep 25, 2026Roberts BrandiChief Financial Officer3,377Common Shares—Sell
Sep 25, 2026Sullivan MarkChief Legal Officer14,051Common Shares—Sell
Sep 25, 2026Wiley Matthew T.Chief Commercial Officer3,097Common Shares—Sell
Sep 25, 2026Barrow RobertChief Executive Officer31,550Common Shares—Sell
Sep 25, 2026Karlin DanielChief Medical Officer10,853Common Shares—Sell
Sep 18, 2026Vallone Carol ADirector1,086Common Shares—Option exercise
Sep 18, 2026Krebs AndreasDirector1,629Common Shares—Option exercise
Sep 14, 2026Barrow RobertChief Executive Officer750,000Common Shares—Grant / award
Sep 14, 2026Roberts BrandiChief Financial Officer125,000Common Shares—Grant / award
Sep 14, 2026Sullivan MarkChief Legal Officer125,000Common Shares—Grant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • History
  • News
  • Insider Transactions